Cargando…

Modeling and Targeting Alzheimer’s Disease With Organoids

Human neurodegenerative diseases, such as Alzheimer’s disease (AD), are not easily modeled in vitro due to the inaccessibility of brain tissue and the level of complexity required by existing cell culture systems. Three-dimensional (3D) brain organoid systems generated from human pluripotent stem ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papaspyropoulos, Angelos, Tsolaki, Magdalini, Foroglou, Nicolas, Pantazaki, Anastasia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145390/ https://www.ncbi.nlm.nih.gov/pubmed/32300301 http://dx.doi.org/10.3389/fphar.2020.00396

Ejemplares similares

Targeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease
por: Mango, Dalila, et al.
Publicado: (2019)

Alzheimer’s disease and primary open-angle glaucoma: is there a connection?
por: Tsolaki, Fani, et al.
Publicado: (2011)

Editorial: Accelerated Translation Using Microphysiological Organoid and Microfluidic Chip Models
por: Benam, Kambez H., et al.
Publicado: (2022)

Targeting Renin–Angiotensin System Against Alzheimer’s Disease
por: Gebre, Abadi Kahsu, et al.
Publicado: (2018)

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
por: Cenini, Giovanna, et al.
Publicado: (2019)

A novel deep learning segmentation model for organoid-based drug screening
por: Wang, Xiaowen, et al.
Publicado: (2022)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

NEU1—A Unique Therapeutic Target for Alzheimer’s Disease
por: Khan, Aiza, et al.
Publicado: (2022)

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing
por: Chen, Wei-Yang, et al.
Publicado: (2021)

Modeling Alzheimer’s disease: from past to future
por: Saraceno, Claudia, et al.
Publicado: (2013)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Open questions in human lung organoid research
por: Hughes, Tessa, et al.
Publicado: (2023)

A Synthetic Hydrogel, VitroGel(®) ORGANOID-3, Improves Immune Cell-Epithelial Interactions in a Tissue Chip Co-Culture Model of Human Gastric Organoids and Dendritic Cells
por: Cherne, Michelle D., et al.
Publicado: (2021)

Therapeutic potential of mGluR5 targeting in Alzheimer's disease
por: Kumar, Anil, et al.
Publicado: (2015)

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug
por: Hughes, Rebecca E., et al.
Publicado: (2016)

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022)

EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
por: Choi, Hee-Jeong, et al.
Publicado: (2023)

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
por: McKee, Chloe G., et al.
Publicado: (2023)

APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer’s disease
por: Lapresa, Rebeca, et al.
Publicado: (2022)

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023)

Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer’s Disease Model Mice Targeting Beta-Amyloid Production
por: Yan, Lingli, et al.
Publicado: (2017)

Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice
por: Chen, Chang-lan, et al.
Publicado: (2022)

Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery
por: Bai, Jing, et al.
Publicado: (2020)

Drug Discovery via Human-Derived Stem Cell Organoids
por: Liu, Fangkun, et al.
Publicado: (2016)

Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies
por: Naderi-Meshkin, Hojjat, et al.
Publicado: (2023)

Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer’s disease
por: Thomas, Sunil, et al.
Publicado: (2023)

Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy
por: Sen, Chandani, et al.
Publicado: (2023)

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016)

Targeting NMDA receptor in Alzheimer’s disease: identifying novel inhibitors using computational approaches
por: Siddiqui, Arif Jamal, et al.
Publicado: (2023)

Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer’s disease
por: Adnan, Mohd, et al.
Publicado: (2023)

Myelin organoids for the study of Alzheimer's disease
por: Cerneckis, Jonas, et al.
Publicado: (2023)

Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
por: Cai, Mudan, et al.
Publicado: (2020)

Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
por: Scuderi, Caterina, et al.
Publicado: (2014)

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016)

A Systematic Strategy for Discovering a Therapeutic Drug for Alzheimer’s Disease and Its Target Molecule
por: Yang, Zhiyou, et al.
Publicado: (2017)

Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer’s disease pathology in mice
por: Bjorkli, Christiana, et al.
Publicado: (2022)

A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
por: Yang, Zhiyou, et al.
Publicado: (2023)

Prevention approaches in a preclinical canine model of Alzheimer’s disease: benefits and challenges
por: Davis, Paulina R., et al.
Publicado: (2014)

Nootropic and Neuroprotective Effects of Dichrocephala integrifolia on Scopolamine Mouse Model of Alzheimer’s Disease
por: Kouémou, Nadège E., et al.
Publicado: (2017)

Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_vec8dl2tvbn89a8s0t9cqd5mj6